Helicobacter pylori Infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Group B Receives Following Medications for 14 Days: Tab Metronidazole 500 mg TDS, Omeprazole 20 mg BID, Amoxicillin 1000 mg BID, Bismuth Subcitrate 135 mg BID. Int
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Dyspeptic Patients with Positive Helicobacterpylori Stool Antigen Test Older than 18 Years Old Persons
Exclusion criteria
Exclusion criteria: No Referring After Taking the Medication Taking Medications for Less than 10 Days Pregnant or Breastfeeding Women Patients with the History of Major Cardiac, Pulmonary, Renal or Hepatic Disease History of Known Side Effects to the Medications of Therapeutic Regimen Taking Antibiotic during the Last Month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori Infection. Timepoint: Four Weeks after the Termination of Treatment. Method of measurement: Helicobacter pylori Stool Antigen Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug Adverse Effects Including: Nausa, Abdominal Pain, Metallic Taste, Diarrhea. Timepoint: Four Weeks after Starting the Treatment. Method of measurement: Questionnaire.;The Tolerance to Accepting the Treatment (Taking Medications more than 10 Days). Timepoint: Two Weeks after Starting the Treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Mohammad Hoseiny Azar
Oroumia University of Medical Sciences
Outcome results
None listed